Is High Dose Therapy Superior to Conventional Dose Therapy as Initial Treatment for Relapsed Germ Cell Tumors? The TIGER Trial

by Darren R. Feldman, Robert Huddart, Emma Hall, Jörg Beyer, Thomas Powles
Published 2011-01-01

Activating Mutations and/or Expression Levels of Tyrosine Kinase Receptors GRB7, RAS, and BRAF in Testicular Germ Cell Tumors

by Alan McIntyre, Brenda Summersgill, Hayley E. Spendlove, Robert Huddart, Richard Houlston, Janet Shipley
Published 2005-12-01

Outcomes of Postchemotherapy Retroperitoneal Lymph Node Dissection from a High-volume UK Centre Compared with a National Data Set

by Adam Kieran Pearce, David Manson-Bahr, Alison Reid, Robert Huddart, Erik Mayer, David L. Nicol
Published 2021-11-01

Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidance

by Rebecca Lewis, Emma Hall, Shaista Hafeez, Emma Patel, Amanda Webster, Karole Warren-Oseni, Vibeke Hansen, Helen McNair, Elizabeth Miles, Robert Huddart
Published 2020-05-01

Quality assuring “Plan of the day” selection in a multicentre adaptive bladder trial: Implementation of a pre-accrual IGRT guidance and assessment module

by Emma Patel, Yat Tsang, Angela Baker, Jenny Callender, Shaista Hafeez, Emma Hall, Vibeke Nordmark Hansen, Rebecca Lewis, Helen McNair, Elizabeth Miles, Robert Huddart
Published 2019-11-01

Histological Features of Sporadic and Familial Testicular Germ Cell Tumors Compared and Analysis of Age-Related Changes of Histology

by Andreas Stang, Mary L. McMaster, Isabell A. Sesterhenn, Elizabeth Rapley, Robert Huddart, Ketil Heimdal, Katherine A. McGlynn, Jan Wolter Oosterhuis, Mark H. Greene
Published 2021-04-01

Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial.

by Jennifer S Walsh, Helen Marshall, Isabelle L Smith, Diana M Greenfield, Jayne Swain, Emma Best, James Ashton, Julia M Brown, Robert Huddart, Robert E Coleman, John A Snowden, Richard J Ross
Published 2019-11-01

SPIRE – combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clini...

by Simon Crabb, Sarah J. Danson, James W. F. Catto, Cathy McDowell, James N. Lowder, Joshua Caddy, Denise Dunkley, Jessica Rajaram, Deborah Ellis, Stephanie Hill, David Hathorn, Amy Whitehead, Mihalis Kalevras, Robert Huddart, Gareth Griffiths
Published 2018-04-01

Rare disruptive mutations in ciliary function genes contribute to testicular cancer susceptibility

by Kevin Litchfield, Max Levy, Darshna Dudakia, Paula Proszek, Claire Shipley, Sander Basten, Elizabeth Rapley, D. Timothy Bishop, Alison Reid, Robert Huddart, Peter Broderick, David Gonzalez de Castro, Simon O'Connor, Rachel H. Giles, Richard S. Houlston, Clare Turnbull
Published 2016-12-01

Genomic landscape of platinum resistant and sensitive testicular cancers

by Chey Loveday, Kevin Litchfield, Paula Z. Proszek, Alex J. Cornish, Flavia Santo, Max Levy, Geoff Macintyre, Amy Holryod, Peter Broderick, Darshna Dudakia, Barbara Benton, Maise Al Bakir, Crispin Hiley, Emily Grist, Charles Swanton, Robert Huddart, Tom Powles, Simon Chowdhury, Janet Shipley, Simon O’Connor, James D. Brenton, Alison Reid, David Gonzalez de Castro, Richard S. Houlston, Clare Turnbull
Published 2020-05-01